You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Checkpoint

Showing 26 - 50 of 2,227
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)

Recruiting
  • Immune Checkpoint Inhibitor
  • +3 more
  • Blood sample
  • Amiens, France
    CHU Amiens
Dec 8, 2022

Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Tampa (Excerise, Checkpoint Blockade,

Recruiting
  • Cutaneous Melanoma
  • +2 more
  • Excerise
  • Checkpoint Blockade, Immune
  • Tampa, Florida
    Moffitt Cancer Center
Sep 21, 2022

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging

Completed
  • Non-small Cell Lung Cancer (NSCLC)
    • Nîmes, France
      Jean-Paul BEREGI
    Jan 25, 2023

    Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)

    Not yet recruiting
    • Fibrolamellar Hepatocellular Carcinoma
    • Tuebingen, Baden-Würtemberg, Germany
      University Hospital Tuebingen
    Jun 29, 2023

    Multiple Myeloma Trial in Rennes (Blood and bone marrow sampling)

    Completed
    • Multiple Myeloma
    • Blood and bone marrow sampling
    • Rennes, France
      CHU Rennes
    Feb 2, 2023

    Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

    Recruiting
    • Lung Squamous Cell Carcinoma
    • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
    • Yancheng, Jiangsu, China
      Yancheng Clinical College of Xuzhou Medical University
    Mar 21, 2023

    Determine Pro-Inflammatory Cytokine Kinetics During Immune

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Melanoma
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Jan 30, 2023

      Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

      Recruiting
      • Advanced Biliary Tract Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 22, 2023

      CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term

      Completed
      • Paraneoplastic Syndromes
      • This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Jul 11, 2023

      Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • +3 more
      • Intensity Modulated Radiation Therapy
      • +3 more
      • (no location specified)
      Jul 11, 2023

      Quality of Life and Physical Fitness After Immune Checkpoint

      Completed
      • Melanoma
      • Non Small Cell Lung Cancer
        • Groningen, Netherlands
          University Medical Center Groningen
        Jan 3, 2023

        Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

        Completed
        • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
        • Wenzhou, Zhejiang, China
          The First Affiliated Hospital of Wenzhou Medical University
        Nov 6, 2023

        Healthcare Resource Utilization and Costs of Immune Checkpoint

        Completed
        • Melanoma
          • East Hanover, New Jersey
            Novartis
          May 12, 2023

          Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

          Not yet recruiting
          • Cervical Cancer
          • Cervical Carcinoma
          • Guangzhou, China
            Sun Yat-sen University Cancer Cetntre
          Apr 9, 2023

          Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Lymphoma, Mantle-Cell
          • (no location specified)
          Dec 22, 2022

          Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

          Recruiting
          • Immunotherapy
          • +5 more
          • blood retriewal
          • Amiens, Picardie, France
            CHU Amiens Picardie
          Apr 3, 2023

          Lung Cancer Trial in Wuhan (Pirfenidone)

          Recruiting
          • Lung Cancer
          • Wuhan, Hubei, China
            Hubei Cancer Hospital
          Mar 24, 2023

          Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

          Not yet recruiting
          • Colitis
          • Aalborg, Denmark
          • +2 more
          Jul 7, 2023

          Lung Cancer, Immune Checkpoint Inhibitor, Radiotherapy Trial in Chongqing (Super-hyperfractionation Pulse Radiotherapy)

          Recruiting
          • Lung Cancer
          • +2 more
          • Super-hyperfractionation Pulse Radiotherapy
          • Chongqing, Chongqing, China
          • +1 more
          Feb 22, 2023

          ImPACt on Invasive Fungal Infections by Immune Checkpoint

          Completed
          • Invasive Fungal Infections
          • No intervention
          • Köln, Germany
            Klinikum der Universität zu Köln
          Oct 31, 2022

          Checkpoint Inhibitors in Triple Negative Breast

          Recruiting
          • Triple Negative Breast Cancer
          • Whole Genome Sequencing
          • +7 more
          • Barcelona, Spain
            Vall d'Hebron Institute of Oncology
          Jun 20, 2023

          Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

          Not yet recruiting
          • Metastatic Pancreatic Cancer
          • Durvalumab
          • Rintatolimod
          • Rotterdam, Zuid-Holland, Netherlands
            Erasmus MC
          Jun 23, 2023

          Advanced Malignant Solid Tumor Trial in Huntersville (BNT314, Pembrolizumab)

          Not yet recruiting
          • Advanced Malignant Solid Tumor
          • BNT314
          • Pembrolizumab
          • Huntersville, North Carolina
            Carolina BioOncology Institute, LLC
          Nov 21, 2023

          Recurrent Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Carcinoma, Chemo Effect Trial in Guangzhou (PD-1 Immune Checkpoint

          Active, not recruiting
          • Recurrent Nasopharyngeal Carcinoma
          • +2 more
          • PD-1 Immune Checkpoint Inhibitor Combined With Bevacizumab
          • Guangzhou, Guangdong, China
            Yanqun Xiang
          Sep 5, 2022